2Mont MA,Carbone JJ, Fairbank AC. Core decompression versusnonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res, 1996, ( 324 ) : 169 - 178.
3Veillette C J, Mehdian H, Schemitsch Eh, et al. Survivorship analysis and radiographic outcome following tantalum rod insertion for osteonecrosis of the femoral head. J Bone Joint Surg Am,2006,88 ( Suppl 3 ) :48 - 55.
2Scully SP,Aaron RK,Urbaniak JR.Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis.J Bone Joint Surg Am,1998; 80(9):1270-1275
3Mont MA,Carbone J J,Fairbank AC.Core decompression versus nonoperative management for osteonecrosis of the hip.Clin Orthop,1996; 324:169-178
4胥少汀,葛宝丰,徐印坎.实用骨科学学[M].北京:人民军医出版社,2005:1822-1825
5Tang CL,Mahoney JL,McKee MD,et al.Donor site morbidity following vascularized fibular grafting.Microsurgery,1998; 18(6):383-386
6Aaron RK,Ciombor DM,Lord CF.Core decompression augmented with human decalcified bone matrix graft for osteonecrosis of the femoral head[A].In:Urbaniak JR,Jones JP Jr,eds.Osteonecrosis:Etiology,Diagnosis and Treatment[M].Rosemont:American Academy of Orthopaedic Surgeons,1997:301-307
7Pedersen DR,Brown TD,Poggie RA.Finite element characterization of a porous tantalum material for treatment of avascular necrosis.Trans Orthop Res Soc,1997; 22:598
8Bobyn JD,Hacking SA,Chan SP,et al.Characterization of a new porous tantalum biomaterial for reconstructive orthopaedics.Presented as a scientific exhibitat the Annual Meeting of the American Academy of Orthopaedic Surgeons,Anaheim,1999:4-8
